BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31837116)

  • 1. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
    Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
    Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
    Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
    BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
    Tian T; Li J; Hu W; Sun C; Zhou J
    J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.
    Zhang F; Hu L; Wang J; Chen J; Chen J; Wang Y
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27976800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
    Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
    Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.
    Verma A; Phua CK; Sim WY; Algoso RE; Tee KS; Lew SJ; Lim AY; Goh SK; Tai DY; Kor AC; Ho B; Abisheganaden J
    Medicine (Baltimore); 2016 Jun; 95(26):e3996. PubMed ID: 27368006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
    Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
    Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
    Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
    Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pleural effusion of multiple myeloma: prognostic factors and outcome.
    Kamble R; Wilson CS; Fassas A; Desikan R; Siegel DS; Tricot G; Anderson P; Sawyer J; Anaissie E; Barlogie B
    Leuk Lymphoma; 2005 Aug; 46(8):1137-42. PubMed ID: 16085553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelomatous pleural effusion: a case series in a single institution and literature review.
    Cho YU; Chi HS; Park CJ; Jang S; Seo EJ; Suh C
    Korean J Lab Med; 2011 Oct; 31(4):225-30. PubMed ID: 22016674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
    Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J
    PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
    Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
    J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine: new tumor marker in pleural fluid.
    Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
    Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
    Zhang F; Wang J; Zheng X; Hu L; Chen J; Jiang F; Wang Y
    J Clin Lab Anal; 2018 Oct; 32(8):e22576. PubMed ID: 29797475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural effusions in lymphoproliferative disorders.
    Ahmed S; Shahid RK; Rimawi R; Siddiqui AK; Rossoff L; Sison CP; Steinberg H; Rai KR
    Leuk Lymphoma; 2005 Jul; 46(7):1039-44. PubMed ID: 16019555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.
    Saraya T; Ohkuma K; Watanabe T; Mikura S; Kobayashi F; Aso J; Nunokawa H; Honda K; Ogawa Y; Tamura M; Sada M; Oda M; Inoue M; Yokoyama T; Kurai D; Ishii H; Kimura H; Takizawa H
    Lung; 2018 Apr; 196(2):249-254. PubMed ID: 29353318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
    Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.